Market Sentiment for VTRS

Live Market Sentiment

Neutral (0.0000)

(Latest daily score)

Predicted Return

-17.93%

7-day sentiment average

Advisory Opinion

Sell

Derived from sentiment trend

News Items (period)

846

The table below gives each of the most recent headlines of the stock and the negative, neutral, positive aggregated sentiment score.

Date	Headline	Source	Sentiment
2026-03-28	Viatris at $14: A Double-Digit FCF Yield Hiding in Plain Sight	GuruFocus.com	Negative (-0.3387)
2026-03-23	Viatris Stock: Is VTRS Outperforming the Health Care Sector?	Barchart	Strong Negative (-0.5437)
2026-03-23	Viatris Advances Innovative Portfolio with Approval of Effexor® in Japan for Adults with Generalized Anxiety Disorder (GAD)	PR Newswire	Strong Positive (0.9053)
2026-03-21	Will Viatris’ 2030 Capital Return And Growth Blueprint Change Viatris' (VTRS) Narrative	Simply Wall St.	Positive (0.2160)
2026-03-20	What Investors Should Know About a $24 Million Exit From a Medical Device Stock Down 9% This Past Year	Motley Fool	Strong Negative (-0.9614)
2026-03-20	Theravance's Q4 Earnings and Revenues Miss Estimates	Zacks	Strong Negative (-0.9481)
2026-03-19	Viatris to Outline its Vision for Sustained Revenue and Earnings Growth Through 2030	PR Newswire	Strong Positive (0.8521)
2026-03-19	Theravance Biopharma, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update	PR Newswire	Neutral (-0.0008)
2026-03-17	1 Cash-Producing Stock to Target This Week and 2 That Underwhelm	StockStory	Negative (-0.1037)
2026-03-15	What Are Analysts Saying About Viatris Inc (VTRS) Stock?	Insider Monkey	Negative (-0.1483)